Praxbind and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Praxbind (idarucizumab) and Lantus (insulin glargine recombinant). Common drug interactions include haemorrhage intracranial among females and blood urine present among males.

The phase IV clinical study analyzes what interactions people have when they take Praxbind and Lantus. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Praxbind?

Praxbind has active ingredients of idarucizumab. eHealthMe is studying from 1,391 Praxbind users. Check the latest studies of Praxbind.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.



On Jul, 13, 2026

15 people who take Praxbind and Lantus together, and have interactions are studied.

Praxbind and Lantus drug interactions.

What are the common drug interactions of Praxbind and Lantus, by gender? *:

female:

  1. Haemorrhage intracranial (bleeding within the skull)
  2. Abdominal pain
  3. Nausea (feeling of having an urge to vomit)
  4. Rectal haemorrhage (bleeding from anus)
  5. Aphasia (damage to the parts of the brain that control language)
  6. Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
  7. Cardiac failure
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Infusion site extravasation (flow of (blood or lymph) from infusion site)

male:

  1. Blood urine present
  2. Epistaxis (bleed from the nose)
  3. Delirium (wild excitement)
  4. Pleural effusion (water on the lungs)
  5. Pneumonia
  6. Urinary tract infection
  7. Chest pain
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Gaze palsy (disorders affecting the ability to move both eyes in the same direction)

What are the common drug interactions of Praxbind and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Blood urine present
  2. Epistaxis (bleed from the nose)
  3. Cardiac failure
  4. Abdominal pain
  5. Delirium (wild excitement)
  6. Nausea (feeling of having an urge to vomit)
  7. Pleural effusion (water on the lungs)
  8. Pneumonia
  9. Rectal haemorrhage (bleeding from anus)
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 40.00%
  2. Type 2 Diabetes: 4 people, 26.67%
  3. High Blood Pressure: 4 people, 26.67%
  4. Haemorrhage (bleeding): 2 people, 13.33%
  5. Shock Haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding): 1 person, 6.67%
  6. Blood Urine Present: 1 person, 6.67%
  7. Breast Neoplasm (non cancerous tumour of breast): 1 person, 6.67%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 6.67%
  9. Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 6.67%
  10. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Praxbind and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Praxbind and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Praxbind:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Praxbind and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on idarucizumab and insulin glargine recombinant (the active ingredients of Praxbind and Lantus, respectively), and Praxbind and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: